Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
0.974
-0.046 (-4.53%)
At close: Dec 20, 2024, 4:00 PM
0.980
+0.006 (0.64%)
After-hours: Dec 20, 2024, 7:59 PM EST
CDIO Revenue
Cardio Diagnostics Holdings had revenue of $6.58K in the quarter ending September 30, 2024, a decrease of -34.40%. This brings the company's revenue in the last twelve months to $35.69K, up 180.90% year-over-year. In the year 2023, Cardio Diagnostics Holdings had annual revenue of $17.07K with 1,696.32% growth.
Revenue (ttm)
$35.69K
Revenue Growth
+180.90%
P/S Ratio
n/a
Revenue / Employee
$3,965
Employees
9
Market Cap
39.38M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 17.07K | 16.12K | 1,696.32% |
Dec 31, 2022 | 950.00 | 49.00 | 5.44% |
Dec 31, 2021 | 901.00 | - | - |
Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCDIO News
- 5 days ago - Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests - Business Wire
- 5 weeks ago - Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference - Business Wire
- 2 months ago - Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests - Business Wire
- 5 months ago - Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions - Business Wire
- 6 months ago - Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois - Business Wire
- 6 months ago - Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum - Business Wire
- 6 months ago - Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality - Business Wire
- 7 months ago - Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services' (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests - Business Wire